68 related articles for article (PubMed ID: 16596343)
1. Chemical shift backbone assignments of TAP-N, the 31 kDa cargo-binding region of the protein TAP.
Pimienta G; Gabel F; Zanier K; Conti E; Sattler M
J Biomol NMR; 2006; 36 Suppl 1():23. PubMed ID: 16596343
[No Abstract] [Full Text] [Related]
2. Modulation of the antigenic peptide transporter TAP by recombinant antibodies binding to the last five residues of TAP1.
Plewnia G; Schulze K; Hunte C; Tampé R; Koch J
J Mol Biol; 2007 May; 369(1):95-107. PubMed ID: 17418234
[TBL] [Abstract][Full Text] [Related]
3. Identification of a contact region for peptide on the TAP1 chain of the transporter associated with antigen processing.
Nijenhuis M; Schmitt S; Armandola EA; Obst R; Brunner J; Hämmerling GJ
J Immunol; 1996 Mar; 156(6):2186-95. PubMed ID: 8690908
[TBL] [Abstract][Full Text] [Related]
4. Recombinant SEC14-like proteins (TAP) possess GTPase activity.
Habermehl D; Kempna P; Azzi A; Zingg JM
Biochem Biophys Res Commun; 2005 Jan; 326(1):254-9. PubMed ID: 15567179
[TBL] [Abstract][Full Text] [Related]
5. Distinct functions and cooperative interaction of the subunits of the transporter associated with antigen processing (TAP).
Karttunen JT; Lehner PJ; Gupta SS; Hewitt EW; Cresswell P
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7431-6. PubMed ID: 11381133
[TBL] [Abstract][Full Text] [Related]
6. Membrane topology and dimerization of the two subunits of the transporter associated with antigen processing reveal a three-domain structure.
Vos JC; Spee P; Momburg F; Neefjes J
J Immunol; 1999 Dec; 163(12):6679-85. PubMed ID: 10586064
[TBL] [Abstract][Full Text] [Related]
7. Backbone chemical shifts assignments of D-allose binding protein in the free form and in complex with D-allose.
Castaño D; Millet O
Biomol NMR Assign; 2011 Apr; 5(1):31-4. PubMed ID: 20711759
[TBL] [Abstract][Full Text] [Related]
8. Use of chimeric proteins to investigate the role of transporter associated with antigen processing (TAP) structural domains in peptide binding and translocation.
Arora S; Lapinski PE; Raghavan M
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7241-6. PubMed ID: 11416206
[TBL] [Abstract][Full Text] [Related]
9. Multiple regions of the transporter associated with antigen processing (TAP) contribute to its peptide binding site.
Nijenhuis M; Hämmerling GJ
J Immunol; 1996 Dec; 157(12):5467-77. PubMed ID: 8955196
[TBL] [Abstract][Full Text] [Related]
10. Detection of TAP family dimerizations by an in vivo assay in mammalian cells.
Leveson-Gower DB; Michnick SW; Ling V
Biochemistry; 2004 Nov; 43(44):14257-64. PubMed ID: 15518576
[TBL] [Abstract][Full Text] [Related]
11. The rational design of TAP inhibitors using peptide substrate modifications and peptidomimetics.
Grommé M; van der Valk R; Sliedregt K; Vernie L; Liskamp R; Hämmerling G; Koopmann JO; Momburg F; Neefjes J
Eur J Immunol; 1997 Apr; 27(4):898-904. PubMed ID: 9130642
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome.
Begley GS; Horvath AR; Taylor JC; Higgins CF
Mol Immunol; 2005 Jan; 42(1):137-41. PubMed ID: 15488952
[TBL] [Abstract][Full Text] [Related]
13. Residues in TAP2 peptide transporters controlling substrate specificity.
Momburg F; Armandola EA; Post M; Hammerling GJ
J Immunol; 1996 Mar; 156(5):1756-63. PubMed ID: 8596024
[TBL] [Abstract][Full Text] [Related]
14. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
Wang F; Li X; Annis B; Faustman DL
Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
[TBL] [Abstract][Full Text] [Related]
15. Disparate peptide-dependent thymic selection outcomes in beta2M-deficient mice versus TAP-1-deficient mice: implications for repertoire formation.
Sasada T; Yang Y; Lai CC; Touma M; Clayton LK; Liu JH; Parisini E; Wang JH; Reinherz EL
Eur J Immunol; 2003 Feb; 33(2):368-80. PubMed ID: 12645934
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the human GINS complex.
Choi JM; Lim HS; Kim JJ; Song OK; Cho Y
Genes Dev; 2007 Jun; 21(11):1316-21. PubMed ID: 17545466
[TBL] [Abstract][Full Text] [Related]
17. TAP and TAP-like--brothers in arms?
Zhao C; Tampé R; Abele R
Naunyn Schmiedebergs Arch Pharmacol; 2006 Mar; 372(6):444-50. PubMed ID: 16525794
[TBL] [Abstract][Full Text] [Related]
18. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
19. A major role for tapasin as a stabilizer of the TAP peptide transporter and consequences for MHC class I expression.
Garbi N; Tiwari N; Momburg F; Hämmerling GJ
Eur J Immunol; 2003 Jan; 33(1):264-73. PubMed ID: 12594855
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism in the mouse Tap-1 gene. Association with abnormal CD8+ T cell development in the nonobese nondiabetic mouse.
Pearce RB; Trigler L; Svaasand EK; Peterson CM
J Immunol; 1993 Nov; 151(10):5338-47. PubMed ID: 8228229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
